164 related articles for article (PubMed ID: 36644819)
1. CircLASP1 silence strengthens the therapeutic effects of MK-2206 on nasopharyngeal cancer through upregulating miR-625.
Xu LN; Liu SL; Yang Y; Shu L; Sun Y
Cancer Sci; 2023 May; 114(5):2123-2138. PubMed ID: 36644819
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
Jiang J; Tang Q; Gong J; Jiang W; Chen Y; Zhou Q; Aldeen A; Wang S; Li C; Lv W; Du T; Wang X; Long X; Feng X
Int J Biol Sci; 2022; 18(5):1878-1895. PubMed ID: 35342334
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Zhang W; Zhang Y; Xi S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
[TBL] [Abstract][Full Text] [Related]
6. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
Deng G; Wang F; Song Y
Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
9. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding domain 2 of nucleolin is important for the autophagy induction of curcumol in nasopharyngeal carcinoma cells.
Liu G; Wang J; Han M; Li X; Zhou L; Dou T; Liu Y; HuangFu M; Guan X; Wang Y; Tang W; Liu Z; Li L; Ding H; Chen X
Phytomedicine; 2023 Jul; 115():154833. PubMed ID: 37137203
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
12. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
Ou H; Li Y; Kang M
PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
[TBL] [Abstract][Full Text] [Related]
13. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
14. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
15. MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1.
Zhou X; Zheng L; Zeng C; Wu Y; Tang X; Zhu Y; Tang S
Anticancer Drugs; 2023 Jan; 34(1):135-143. PubMed ID: 36539366
[TBL] [Abstract][Full Text] [Related]
16. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.
Ma BB; Lui VW; Hui CW; Lau CP; Wong CH; Hui EP; Ng MH; Tsao SW; Li Y; Chan AT
Invest New Drugs; 2013 Jun; 31(3):567-75. PubMed ID: 23143779
[TBL] [Abstract][Full Text] [Related]
18. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
[TBL] [Abstract][Full Text] [Related]
19. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
